Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)

Completed · Phase 1

Conditions studied: Post-Traumatic Stress Disorder

In brief

This is a double-blind, placebo-controlled, randomized study lasting 8 weeks. Purpose of the study is two-fold: first, to use a pharmacological agent to treat symptoms of PTSD, and second, to explore neurobiological mechanisms of action of guanfacine.

Key facts

Study ID

NCT00018603

Run by

US Department of Veterans Affairs

Starts

1999-11-01

Expected to finish

2002-10-01

Last updated by the study team

2009-01-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• VA Connecticut Healthcare System — West Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.